Literature DB >> 27026656

Reduced cerebrovascular reserve is regionally associated with cortical thickness reductions in children with sickle cell disease.

Junseok A Kim1, Jackie Leung2, Jason P Lerch3, Andrea Kassner4.   

Abstract

Sickle cell disease (SCD) is a genetic disorder which adversely affects cerebrovascular health. Previous studies have demonstrated regional cortical thinning in SCD. However, the reason behind regional reductions in cortical thickness remains unclear. Therefore, we aimed to explore the possible link between the state of cerebrovascular health and cortical thickness. In this study, we obtained magnetic resonance (MR) based measures of cerebrovascular reactivity (CVR), a measure of vascular health, and cortical thickness in SCD patients (N=60) and controls of similar age and similar gender ratio (N=27). The group comparison analysis revealed significant regionally specific reductions in CVR and cortical thickness in the SCD group compared to the controls. In addition, a regional association analysis was performed between CVR and cortical thickness in the SCD group which revealed a significant regional association in several brain regions with the highest strength of association observed in the left cuneus, right post central gyrus and the right temporal pole. The regional association analysis revealed that significant associations were found in brain regions with high metabolic activity (anterior cingulate, posterior cingulate, occipital gyrus, precuneus) thus demonstrating that these regions could be most vulnerable to structural damage under hypoxic conditions.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Blood oxygen level dependent imaging; Cerebrovascular reactivity; Cortical thickness; Magnetic resonance imaging; Pediatric; Sickle cell disease

Mesh:

Year:  2016        PMID: 27026656     DOI: 10.1016/j.brainres.2016.03.041

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

1.  Differences in Activation and Deactivation in Children with Sickle Cell Disease Compared with Demographically Matched Controls.

Authors:  B Sun; R C Brown; T G Burns; D Murdaugh; S Palasis; R A Jones
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-13       Impact factor: 3.825

2.  Functional and anatomical evidence of cerebral tissue hypoxia in young sickle cell anemia mice.

Authors:  Lindsay S Cahill; Lisa M Gazdzinski; Albert Ky Tsui; Yu-Qing Zhou; Sharon Portnoy; Elaine Liu; C David Mazer; Gregory Mt Hare; Andrea Kassner; John G Sled
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-20       Impact factor: 6.200

Review 3.  Neuroimaging of vascular reserve in patients with cerebrovascular diseases.

Authors:  Meher R Juttukonda; Manus J Donahue
Journal:  Neuroimage       Date:  2017-10-12       Impact factor: 6.556

4.  Hydroxycarbamide and white matter integrity in pediatric sickle cell disease: Commentary to accompany: Hydroxycarbamide treatment in children with sickle cell anaemia is associated with more intact white matter integrity: a quantitative MRI study.

Authors:  Eboni I Lance; Lori C Jordan
Journal:  Br J Haematol       Date:  2019-10       Impact factor: 6.998

5.  Neurodevelopmental Outcomes in Preterm Children with Sickle Cell Disease.

Authors:  Sarah E Bills; Jeffrey Schatz; Erin Hunt; Sreya Varanasi; Julia Johnston; Jessica Bradshaw
Journal:  J Int Neuropsychol Soc       Date:  2021-11-29       Impact factor: 3.114

6.  Individual Watershed Areas in Sickle Cell Anemia: An Arterial Spin Labeling Study.

Authors:  Hanne Stotesbury; Patrick W Hales; Anna M Hood; Melanie Koelbel; Jamie M Kawadler; Dawn E Saunders; Sati Sahota; David C Rees; Olu Wilkey; Mark Layton; Maria Pelidis; Baba P D Inusa; Jo Howard; Subarna Chakravorty; Chris A Clark; Fenella J Kirkham
Journal:  Front Physiol       Date:  2022-05-03       Impact factor: 4.755

7.  MRI-based cerebrovascular reactivity using transfer function analysis reveals temporal group differences between patients with sickle cell disease and healthy controls.

Authors:  Jackie Leung; James Duffin; Joseph A Fisher; Andrea Kassner
Journal:  Neuroimage Clin       Date:  2016-09-13       Impact factor: 4.881

8.  Vascular Instability and Neurological Morbidity in Sickle Cell Disease: An Integrative Framework.

Authors:  Hanne Stotesbury; Jamie M Kawadler; Patrick W Hales; Dawn E Saunders; Christopher A Clark; Fenella J Kirkham
Journal:  Front Neurol       Date:  2019-08-13       Impact factor: 4.003

9.  Venous cerebral blood flow quantification and cognition in patients with sickle cell anemia.

Authors:  Hanne Stotesbury; Patrick W Hales; Melanie Koelbel; Anna M Hood; Jamie M Kawadler; Dawn E Saunders; Sati Sahota; David C Rees; Olu Wilkey; Mark Layton; Maria Pelidis; Baba Pd Inusa; Jo Howard; Subarna Chakravorty; Chris A Clark; Fenella J Kirkham
Journal:  J Cereb Blood Flow Metab       Date:  2022-01-06       Impact factor: 6.960

10.  MRI detection of brain abnormality in sickle cell disease.

Authors:  Hanne Stotesbury; Jamie Michelle Kawadler; Dawn Elizabeth Saunders; Fenella Jane Kirkham
Journal:  Expert Rev Hematol       Date:  2021-06-07       Impact factor: 2.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.